CPM DPM Part 1 Practice Questions - Certificate In Pharmaceutical Medicine Exam

Access More Questions

Co-administration of a potent CYP3A4 inhibitor with an investigational drug that is a sensitive CYP3A4 substrate is expected to cause which pharmacokinetic change?

Increased Area Under the Curve (AUC) and prolonged elimination half-life of the investigational drug. Decreased Cmax and increased clearance of the investigational drug. Reduced oral absorption due to P-glycoprotein activation in the enterocytes. Accelerated hepatic biotransformation leading to subtherapeutic blood levels.

Correct Answer:

Increased Area Under the Curve (AUC) and prolonged elimination half-life of the investigational drug.

Access more questions from this quiz

Continue to CPM DPM Part 1 Practice Questions - Certificate in Pharmaceutical Medicine Exam for more practice questions and the full quiz experience.

Access More Questions